{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:15:46Z","timestamp":1776820546983,"version":"3.51.2"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ad.2015.06.005","type":"journal-article","created":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T17:31:59Z","timestamp":1439400719000},"page":"716-724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Actualizaci\u00f3n en hidradenitis supurativa (ii): aspectos terap\u00e9uticos"],"prefix":"10.1016","volume":"106","author":[{"given":"A.","family":"Martorell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Jim\u00e9nez-Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pereyra-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Villarrasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2015.06.005_bib0230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/derm.2.1.12490","article-title":"Comorbidities of hidradenitis suppurativa (acne inversa)","volume":"2","author":"Fimmel","year":"2010","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.ad.2015.06.005_bib0235","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2015.06.005_bib0240","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40257-015-0118-8","article-title":"The medical and laser management of hidradenitis suppurativa","volume":"16","author":"Hughes","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0245","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa","volume":"39","author":"Jemec","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0250","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","article-title":"Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: A series of 116 consecutive patients","volume":"219","author":"Gener","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2015.06.005_bib0255","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archdermatol.2011.1950","article-title":"A systematic review of treatments for hidradenitis suppurativa","volume":"148","author":"Rambhatla","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0260","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bjd.12884","article-title":"Acitretin treatment for hidradenitis suppurativa: A prospective series of 17 patients","volume":"171","author":"Matusiak","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0265","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000329023","article-title":"Dapsone therapy for hidradenitis suppurativa: A series of 24 patients","volume":"222","author":"Yazdanyar","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2015.06.005_bib0270","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjd.12104","article-title":"Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: A systematic review","volume":"168","author":"Blok","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0275","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.2310\/7750.2012.11144","article-title":"Adalimumab in treatment-resistant hidradenitis suppurativa following recurrence after extensive affected area excision: A review of biologics therapy","volume":"17","author":"Samycia","year":"2013","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.ad.2015.06.005_bib0280","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2133.2011.10339.x","article-title":"A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa","volume":"165","author":"Miller","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0285","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: A parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ad.2015.06.005_bib0290","first-page":"s15","article-title":"A prospective open-label clinical trial of efficacy of the every week administration of adalimumab in the treatment of hidradenitis suppurativa","volume":"11","author":"Sotiriou","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0295","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jdv.12438","article-title":"Use of biological treatments in patients with hidradenitis suppurativa","volume":"29","author":"Martin-Ezquerra","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2015.06.005_bib0300","unstructured":"Jemec GBE, Gottlieb A, Forman S, Mrowietz U, Gelfand JM, Gniadecki R, et al. Efficacy and safety of adalimumab in patients with moderate to severe hidradenitis suppurativa: Results from PIONEER II, a phase 3 randomized placebo-controlled trial. Abstract presented at: European Academy of Dermatology and Venereology; October 8-12, 2014; Amsterdam, Netherlands. Abstract FC08.3."},{"key":"10.1016\/j.ad.2015.06.005_bib0305","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: A rationale for targeting TNF-\u03b1 and IL-1\u03b2","volume":"164","author":"Van der Zee","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0310","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/bjd.12713","article-title":"Four-weekly infliximab in the treatment of severe hidradenitis suppurativa","volume":"170","author":"Moriarty","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0315","doi-asserted-by":"crossref","DOI":"10.5070\/D35VW402NF","article-title":"Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients","volume":"19","author":"Scheinfeld","year":"2013","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ad.2015.06.005_bib0320","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamadermatol.2013.2874","article-title":"Finasteride for the treatment of hidradenitis suppurativa in children and adolescents","volume":"149","author":"Randhawa","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0325","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2230.2002.11125.x","article-title":"Methotrexate is of limited value in the treatment of hidradenitis suppurativa","volume":"27","author":"Jemec","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0330","first-page":"55","article-title":"Alitretinoin: A useful agent in the treatment of hidradenitis suppurativa, especially in women of child bearing age","volume":"150","author":"Verdolini","year":"2015","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.ad.2015.06.005_bib0335","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/j.jaad.2014.06.031","article-title":"Hidradenitis suppurativa after renal transplantation: Complete remission after switching from oral cyclosporine to oral tacrolimus","volume":"71","author":"Ducroux","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0340","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1684\/ejd.2013.2018","article-title":"Pyoderma gangrenosum and concomitant hidradenitis suppurativa--rapid response to canakinumab (anti-IL-1\u03b2)","volume":"23","author":"Jaeger","year":"2013","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0345","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.coi.2013.12.004","article-title":"Molecular determinants of sterile inflammation","volume":"26","author":"Kono","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ad.2015.06.005_bib0350","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2340\/00015555-1229","article-title":"Management of recalcitrant hidradenitis suppurativa with ustekinumab","volume":"92","author":"Sharon","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2015.06.005_bib0355","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1524-4725.2011.02186.x","article-title":"Hidradenitis suppurativa: Surgical and other management techniques","volume":"38","author":"Ellis","year":"2012","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ad.2015.06.005_bib0360","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","article-title":"Hidradenitis suppurativa: A comprehensive review","volume":"60","author":"Alikhan","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0365","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1742-481X.2006.00235.x","article-title":"Surgical treatment of hidradenitis suppurativa: Case series and review of the literature","volume":"3","author":"Ather","year":"2006","journal-title":"Int Wound J"},{"key":"10.1016\/j.ad.2015.06.005_bib0370","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7150\/ijms.7.240","article-title":"Surgical management of hidradenitis suppurativa","volume":"7","author":"Menderes","year":"2010","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.ad.2015.06.005_bib0375","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bpobgyn.2014.07.012","article-title":"Hidradenitis suppurativa","volume":"28","author":"Margesson","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ad.2015.06.005_bib0380","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1524-4725.2011.02255.x","article-title":"Surgical treatment of sinuses by deroofing in hidradenitis suppurativa","volume":"38","author":"Van Hattem","year":"2012","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ad.2015.06.005_bib0385","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/jdv.12952","article-title":"Surgery under general anaesthesia in severe hidradenitis suppurativa: A study of 363 primary operations in 113 patients","volume":"29","author":"Blok","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2015.06.005_bib0390","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1468-3083.2012.04646.x","article-title":"Secondary intention healing in skin surgery: Our own experience and expanded indications in hidradenitis suppurativa, rhinophyma and non-melanoma skin cancers","volume":"27","author":"Bieniek","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2015.06.005_bib0395","article-title":"A review of wide surgical excision of hidradenitis suppurativa","volume":"12","author":"Alharbi","year":"2012","journal-title":"BMC Dermatol [Internet]"},{"key":"10.1016\/j.ad.2015.06.005_bib0400","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1524-4725.2000.00043.x","article-title":"Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa","volume":"26","author":"Rompel","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ad.2015.06.005_bib0405","doi-asserted-by":"crossref","first-page":"370e","DOI":"10.1097\/PRS.0000000000000080","article-title":"Management of hidradenitis suppurativa wounds with an internal vacuum-assisted closure device","volume":"133","author":"Chen","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ad.2015.06.005_bib0410","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1524-4725.2009.01427.x","article-title":"Hidradenitis suppurativa: Successful treatment using carbon dioxide laser excision and marsupialization","volume":"36","author":"Hazen","year":"2010","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ad.2015.06.005_bib0415","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/PRS.0b013e31821e6fb5","article-title":"Treatment of hidradenitis suppurativa with intense pulsed light: A prospective study","volume":"128","author":"Highton","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ad.2015.06.005_bib0420","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaad.2009.07.048","article-title":"Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser","volume":"62","author":"Mahmoud","year":"2010","journal-title":"J Am Acad Dermatol [Internet]"},{"key":"10.1016\/j.ad.2015.06.005_bib0425","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/ced.12459","article-title":"New topical photodynamic therapy for treatment of hidradenitis suppurativa using methylene blue niosomal gel: A single-blind, randomized, comparative study","volume":"40","author":"Fadel","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0430","doi-asserted-by":"crossref","DOI":"10.5070\/D3211025433","article-title":"The use of photodynamic therapy to treat hidradenitis suppurativa a review and critical analysis","volume":"21","author":"Scheinfeld","year":"2015","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ad.2015.06.005_bib0435","first-page":"370e","article-title":"Treatment of hidradenitis suppurativa with intralesional photodynamic therapy using a laser diode attached to an optical cable: A promising new approach","volume":"105","author":"Scheinfeld","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0440","first-page":"286","article-title":"Radiotherapy of hidradenitis suppurativa--still valid today?","volume":"176","author":"Fr\u00f6hlich","year":"2000","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ad.2015.06.005_bib0445","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jamadermatol.2014.430","article-title":"Cryoinsufflation for Hurley stage II hidradenitis suppurativa: A useful treatment option when systemic therapies should be avoided","volume":"150","author":"Pagliarello","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2015.06.005_bib0450","doi-asserted-by":"crossref","unstructured":"Martorell A. Acercamiento a la hidradenitis supurativa. 1.\u00b0 ed. Madrid:Editorial Aula;2015 en prensa.","DOI":"10.1016\/S0001-7310(16)30007-2"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731015002902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731015002902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:03:30Z","timestamp":1757552610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731015002902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0001731015002902"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2015.06.005","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actualizaci\u00f3n en hidradenitis supurativa (ii): aspectos terap\u00e9uticos","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2015.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Espa\u00f1a, S.L.U. and AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}